Amyloid Goiter in Familial Mediterranean Fever: Description of 42 Cases from a French Cohort and from Literature Review.

AA amyloidosis familial Mediterranean fever goiter

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
05 May 2021
Historique:
received: 17 04 2021
revised: 29 04 2021
accepted: 02 05 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

Our aim was to describe the main features of amyloid goiter in adults with amyloidosis secondary to familial Mediterranean fever. Therefore, we analyzed cases from a French cohort of familial Mediterranean fever patients with amyloidosis and from literature review. Forty-two cases were identified: 9 from the French cohort and 33 from literature review. Ninety percent of patients were on hemodialysis for renal amyloidosis before the development of goiter. The goiter grew up rapidly in 88% of cases; 75.6% of patients were euthyroid, 58% displayed dyspnea, and 44.8% dysphagia. Various features were seen on ultrasound, from diffuse to multinodular goiter. When it was performed, fine-needle aspiration biopsy almost always revealed amyloidosis. Thirty-one patients underwent thyroidectomy: to manage compressive symptoms (72%) or rule out malignancy (27%). Histology showed mature adipose tissue in 64% of cases and lymphocytic infiltration in 21.4%. In conclusion, amyloid goiter in familial Mediterranean fever preferentially occurs in patients with end stage renal failure. Fine-needle aspiration biopsy seems to be a sensitive exam for diagnosis, but thyroidectomy remains sometimes necessary to rule out malignancy or release compressive symptoms.

Identifiants

pubmed: 34063105
pii: jcm10091983
doi: 10.3390/jcm10091983
pmc: PMC8125620
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Auris Nasus Larynx. 2012 Oct;39(5):549-51
pubmed: 22075140
Thyroid. 2001 Apr;11(4):397-400
pubmed: 11349841
J Ultrasound Med. 2010 Aug;29(8):1251-5
pubmed: 20660462
Clin Rheumatol. 2002 Nov;21(6):497-500
pubmed: 12447634
Pediatr Nephrol. 1997 Apr;11(2):210-2
pubmed: 9090667
Diagnostics (Basel). 2020 Apr 23;10(4):
pubmed: 32340182
Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii35-iii40
pubmed: 30281126
Amyloid. 2012 Sep;19(3):161-2
pubmed: 22663145
Turk Patoloji Derg. 2013;29(2):146-9
pubmed: 23661354
Cancer. 1966 Aug;19(8):1039-52
pubmed: 5916581
Ann Saudi Med. 2009 Mar-Apr;29(2):138-41
pubmed: 19318742
Mater Sociomed. 2011;23(4):206-9
pubmed: 26664295
Thyroid. 2013 Nov;23(11):1490-5
pubmed: 23544771
Clin Endocrinol (Oxf). 1997 Jun;46(6):769-74
pubmed: 9274710
Eur J Endocrinol. 2009 Apr;160(4):503-15
pubmed: 19095779
Clin Endocrinol (Oxf). 1979 Dec;11(6):595-601
pubmed: 119593
Cytopathology. 2006 Oct;17(5):262-6
pubmed: 16961655
Rheumatol Int. 2010 Nov;30(12):1647-9
pubmed: 19711078
Ann Intern Med. 1949 Jul;31(1):105-19
pubmed: 18134812
Endocr Rev. 1996 Feb;17(1):45-63
pubmed: 8641223
Arch Iran Med. 2012 Jun;15(6):389-90
pubmed: 22642254
Nephrol Dial Transplant. 1995;10(8):1473
pubmed: 8538953
J Ultrasound Med. 2017 May;36(5):1045-1049
pubmed: 28258641
Am J Clin Pathol. 1995 Sep;104(3):306-12
pubmed: 7677120
J Pediatr Endocrinol. 1994 Oct-Dec;7(4):371-2
pubmed: 7735378
N Engl J Med. 1981 Sep 3;305(10):586
pubmed: 7254261
Balkan Med J. 2014 Sep;31(3):261-3
pubmed: 25337425
Ren Fail. 2001 Sep;23(5):659-67
pubmed: 11725912
Am J Med. 1971 Mar;50(3):336-9
pubmed: 5553952
Isr Med Assoc J. 2012 Apr;14(4):232-3
pubmed: 22675840
Clin Chim Acta. 1991 Aug 30;200(2-3):191-9
pubmed: 1777968
Am J Med. 1967 Aug;43(2):227-53
pubmed: 5340644

Auteurs

Hélène Vergneault (H)

Internal Medicine Department and National Reference Center for Autoinflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), APHP, Tenon Hospital, Sorbonne University, 4 rue de la Chine, 75020 Paris, France.

Alexandre Terré (A)

Internal Medicine Department and National Reference Center for Autoinflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), APHP, Tenon Hospital, Sorbonne University, 4 rue de la Chine, 75020 Paris, France.

David Buob (D)

Department of Pathology, APHP, Tenon Hospital, Sorbonne University, 4 rue de la Chine, 75020 Paris, France.

Camille Buffet (C)

Thyroid Pathologies and Endocrine Tumor Department, APHP, Pitié-Salpêtrière Hospital, Sorbonne University, 47-83 Boulevard de l'Hôpital, 75013 Paris, France.

Anael Dumont (A)

Department of Internal Medicine, Caen University Hospital, Avenue de la Côte de Nacre, 14000 Caen, France.

Samuel Ardois (S)

Department of Internal Medecine, Rennes Medical University, 2 rue Henri le Guilloux, 35000 Rennes, France.

Léa Savey (L)

Internal Medicine Department and National Reference Center for Autoinflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), APHP, Tenon Hospital, Sorbonne University, 4 rue de la Chine, 75020 Paris, France.

Agathe Pardon (A)

Dialysis Center, CH Sud Francilien, 40 Avenue Serge Dassault, 91100 Corbeil-Essonnes, France.

Pierre-Antoine Michel (PA)

Department of Nephrology, APHP, Tenon Hospital, 4 rue de la Chine, 75020 Paris, France.

Jean-Jacques Boffa (JJ)

Department of Nephrology, APHP, Tenon Hospital, 4 rue de la Chine, 75020 Paris, France.

Gilles Grateau (G)

Internal Medicine Department and National Reference Center for Autoinflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), APHP, Tenon Hospital, Sorbonne University, 4 rue de la Chine, 75020 Paris, France.

Sophie Georgin-Lavialle (S)

Internal Medicine Department and National Reference Center for Autoinflammatory Diseases and Inflammatory Amyloidosis (CEREMAIA), APHP, Tenon Hospital, Sorbonne University, 4 rue de la Chine, 75020 Paris, France.

Classifications MeSH